Novo Nordisk becomes second company to announce cuts to US insulin prices
Danish pharmaceutical company Novo Nordisk announced on Tuesday it would be lowering the prices of some of its insulin products in the U.S. by up to 75 percent, becoming the second company to take such action after Eli Lilly’s…